Recommended content

Psilocybin at least as effective in treating depression as a leading antidepressant: Study

New research published in The New England Journal of Medicine suggests that psilocybin could be as effective as selective serotonin reuptake inhibitors in treating depression.

The Imperial College London trial compared psilocybin to escitalopram, a leading antidepressant medication.

Fifty-nine patients with longstanding moderate to severe major depressive disorder took part in the phase 2, double-blind, randomized, controlled trial over a six-week period.

The patients ranged in age from 18 to 80. Thirty were assigned to the psilocybin group and 29 to the escitalopram group.

Both groups were instructed to take a capsule each morning. The psilocybin group was given a placebo while the escitalopram group received a standard dose of the antidepressant medication.

Story continues below

This advertisement has not loaded yet, but your article continues below.

Read full article on The Growth Op

Follow us on Instagram or join us on facebook page

Be first to rate

The Growth Op
Source

More news